We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-12.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$334B
AUM Growth
-$65.4B
Cap. Flow
-$11.7B
Cap. Flow %
-3.51%
Top 10 Hldgs %
13.97%
Holding
7,016
New
146
Increased
2,663
Reduced
3,412
Closed
209

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 10.36%
3 Financials 9.14%
4 Consumer Discretionary 7.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFTY icon
5451
CapForce IBD 50 ETF
FFTY
$79.5M
$92K ﹤0.01%
3,333
-4,068
-55% -$126K
MTEM
5452
DELISTED
Molecular Templates, Inc.
MTEM
$92K ﹤0.01%
1,514
-115
-7% -$8.02K
OTIC
5453
DELISTED
Otonomy, Inc.
OTIC
$92K ﹤0.01%
49,560
-26,629
-35% -$62.8K
PSAU
5454
DELISTED
Invesco Global Gold and Precious Metals ETF
PSAU
$91K ﹤0.01%
5,212
+350
+7% +$5.66K
CVM icon
5455
CEL-SCI Corp
CVM
$20.3M
$90K ﹤0.01%
1,041
+541
+108% +$52.1K
ICCC icon
5456
ImmuCell
ICCC
$101M
$90K ﹤0.01%
12,732
+1,000
+9% +$7.73K
AGTC
5457
DELISTED
Applied Genetic Technologies Corporation
AGTC
$90K ﹤0.01%
36,287
-1,908
-5% -$11.2K
FBSS
5458
DELISTED
Fauquier Bankshares Inc
FBSS
$90K ﹤0.01%
4,715
UQM
5459
DELISTED
UQM Technologies, Inc.
UQM
$90K ﹤0.01%
106,076
-9,000
-8% -$10.8K
LYTS icon
5460
LSI Industries
LYTS
$859M
$89K ﹤0.01%
27,980
-25,175
-47% -$105K
MDWD icon
5461
MediWound
MDWD
$181M
$89K ﹤0.01%
3,156
+983
+45% +$38.2K
SGYP
5462
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$89K ﹤0.01%
785,270
-70,252
-8% -$46.1K
RSXJ
5463
DELISTED
VanEck Russia Small-Cap ETF
RSXJ
$89K ﹤0.01%
3,287
APPS icon
5464
Digital Turbine
APPS
$975M
$88K ﹤0.01%
48,444
+44,839
+1,244% +$70.8K
STRO icon
5465
Sutro Biopharma
STRO
$401M
$88K ﹤0.01%
+980
New +$118K
TAYD icon
5466
Taylor Devices
TAYD
$165M
$88K ﹤0.01%
7,186
+1
+0% +$12
ACGN
5467
DELISTED
Aceragen Inc
ACGN
$87K ﹤0.01%
1,842
-78
-4% -$8.97K
HGI
5468
DELISTED
Invesco Zacks International Multi-Asset Income ETF
HGI
$87K ﹤0.01%
6,185
-1,129
-15% -$16.8K
BW icon
5469
Babcock & Wilcox
BW
$1.39B
$86K ﹤0.01%
22,131
-3,551
-14% -$31.6K
TZOO icon
5470
Travelzoo
TZOO
$74.3M
$86K ﹤0.01%
8,783
-18,298
-68% -$172K
FCOR icon
5471
Fidelity Corporate Bond ETF
FCOR
$351M
$85K ﹤0.01%
1,784
+1,534
+614% +$73K
INSG icon
5472
Inseego
INSG
$114M
$85K ﹤0.01%
2,054
+1,937
+1,656% +$71.8K
ORMP icon
5473
Oramed Pharmaceuticals
ORMP
$167M
$85K ﹤0.01%
28,394
-1,040
-4% -$4.31K
TGB
5474
Trekor Metals
TGB
$2.48B
$85K ﹤0.01%
180,700
-126,000
-41% -$81K
AMPE
5475
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$85K ﹤0.01%
716
-281
-28% -$43.1K

Similar funds

Morgan Stanley's Q4 2018 Portfolio in Review

As of Q4 2018, Morgan Stanley held 7,016 positions worth $334B, down 16% from $400B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley withdrew a net $11.7B in Q4 2018, closing 209 positions and reducing 3,412 holdings. Its most notable exit was Praxair Inc, an estimated $398M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Morgan Stanley opened a new position in Linde worth $342M.

  • Morgan Stanley's largest Q4 2018 buy was Linde: 2,188,871 shares worth $342M.
  • Morgan Stanley added most to People Inc in Q4 2018, an estimated $558M increase.
  • Morgan Stanley's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Morgan Stanley fully exited Praxair Inc in Q4 2018, selling an estimated $398M.
  • Morgan Stanley's ten largest holdings make up 14% of its $334B portfolio in Q4 2018.
  • Morgan Stanley opened 146 new positions and closed 209 in Q4 2018.
  • Morgan Stanley's portfolio value fell 16% quarter-over-quarter to $334B.

Based on Morgan Stanley's 13F filing for Q4 2018, filed 14 Feb 2019.